FilingReader Intelligence
Wantai Bio's nine-valent HPV vaccine gets batch release approval
August 21, 2025 at 05:03 PM UTC•By FilingReader AI
Beijing Wantai Biological Pharmacy announced its nine-valent human papillomavirus vaccine has received batch release approval from the National Institutes for Food and Drug Control.
The approval marks the official market launch of the vaccine, produced by subsidiary Xiamen Wantai Canghai Biotechnology.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:603392•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Beijing Wantai Biological Pharmacy Enterprise publishes news
Free account required • Unsubscribe anytime